Generate a tailored SOP for Dr. Gregory Hockerman. Improve your application with a focused, well-structured draft.
Gregory H. Hockerman is a Professor and Associate Head in the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University. He specializes in molecular pharmacology, particularly focusing on voltage-gated calcium channels and their roles in various physiological processes. His research aims to contribute to drug development targeting voltage-gated calcium channels to treat cardiovascular and neurological diseases, as well as type II diabetes. Hockerman's lab investigates subtype-selective modulation of L-type voltage-gated Ca2+ channels, exploring the distinct biophysical properties of Ca v 1.2 and Ca v 1.3 channels. His work has significant implications in understanding insulin secretion mechanisms and their regulation. Hockerman has published numerous articles in peer-reviewed journals and actively engages in teaching, co-coordinating several courses at the Indiana University School of Medicine - West Lafayette. His long-term research interests include understanding the roles of RYR2 and IRBIT in pancreatic beta-cells, contributing to insight in glucose-stimulated insulin secretion. He has collaborated extensively to discover selective inhibitors that can modulate calcium channel activity, providing potential therapeutic benefits for various diseases.
Purdue University • West Lafayette, IN
Oversees departmental operations and administration, coordinating faculty activities.
Purdue University • West Lafayette, IN
Teaches courses in medicinal chemistry and pharmacology, supervises research projects.
University of Washington • Seattle, WA
Conducted advanced research in pharmacology and calcium signaling.
GRE scores (General and Subject) are NOT considered.